MEDESIS PHARMA : ENREGISTREMENT EN EURASIE DU BREVET DE PROTECTION DU CANDIDAT MEDICAMENT POUR LA DECORPORATION DU CESIUM

12 Dec 2022 18:00 CET

Subscribe
Issuer

MEDESIS PHARMA S.A.

See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo

16165_1125259_CP_BrevetEurasieDecembre2022_Vdef_FR.pdf

Source

MEDESIS PHARMA

Provider

Les Echos

Company Name

MEDESIS PHARMA S.A.

ISIN

FR0010844464

Symbol

ALMDP

Market

Euronext Growth

Attachments

Disclaimer

Medesis Pharma SA published this content on 12 December 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 December 2022 17:13:03 UTC.